01—Abstract
Summary
Summary of the 10-Q filed October 31, 2025. Cited figures are marked; the original filing is the authoritative source.
Linde plc's third-quarter 2025 10-Q shows continued operational momentum.
Q3 sales rose 3% to $8,615 milliona, driven mainly by 2% higher price attainment, 1% from acquisitions and 1% from currency, with flat volumes. Reported operating profit grew 13% to $2,367 million and reported diluted EPS rose 27% to $4.09, though much of the reported improvement reflects lower cost reduction charges and lower merger-related purchase accounting amortization. On an adjusted basis, operating profit grew 3% to $2,558 million (29.7% margin) and adjusted diluted EPS rose 7% to $4.21.
For the nine months, adjusted EPS grew 6% to $12.26b and operating cash flow rose 11% to $7,320 million. The balance sheet expanded meaningfully. Total assets reached $85.99 billion, up from $80.15 billion at year-end 2024, driven by higher PP&E from a $3.8 billion capex program tied to backlog growth and a $5.3 billion receivables balance.
Total debt rose to $25.9 billionc from $21.6 billion, including $5.0 billion of short-term debt, and the company issued multiple euro, Swiss franc and other bonds during the period. Linde continued returning capital, repurchasing $3.2 billion of shares and paying $2.1 billion in dividends, with the quarterly dividend raised 8% to $1.50 per share. Free cash flow after capex was roughly $3.5 billion year to date.
The principal risk flagged is ongoing Russia-related litigation with RusChemAlliance and Gazprom. Linde reports contingent liabilities of about $1.9 billiond for Russia matters and a $0.7 billion Amur GPP contingency, plus a $1.2 billion contingent liability tied to terminated RCA engineering projects. Management believes these will not have a material adverse earnings impact, but timing is uncertain.
The Brazilian Refis tax dispute and the Linde AG appraisal appeal also remain open. Engineering sales declined 15% in Q3 on project timing, and volumes in EMEA fell.
02—Key points
Key Highlights
- Q3 2025 sales of $8.6B (+3% YoY); adjusted operating margin of 29.7%, with growth driven by price (+2%) and acquisitions (+1%), while volumes were flat.
- Reported diluted EPS of $4.09 (+27%); adjusted diluted EPS of $4.21 (+7%), with adjusted net income up 5% to $1.99B for the quarter.
- Operating cash flow of $7.3B for the nine months (+11%); capex of $3.8B (up $556M) supports backlog growth, with $7.1B of large plant projects under construction.
- Total debt rose to $25.9B from $21.6B at year-end 2024, reflecting bond issuances in euros and Swiss francs and higher commercial paper of $4.7B.
- Shareholder returns of $3.2B in buybacks and $2.1B in dividends year to date; $8.7B remains authorized under the 2023 repurchase program; quarterly dividend raised 8% to $1.50.
- Russia exposure remains material: $1.9B of liabilities recorded for RCA matters, a $1.2B contingent liability for terminated RCA projects, and a $0.7B Amur GPP contingency, with resolution timing uncertain.
- Engineering segment sales fell 15% in Q3 on project timing, while EMEA reported a 11% increase in segment operating profit, partly from favorable currency translation and tax rate changes.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ3 FY2025filed October 31, 2025Financial Statements
Q3 FY2025 against Q3 FY2024
| Line item | Q3 FY2025Q3 FY2024 | Change |
|---|---|---|
| Revenue | $8.62B$8.36B | +3.1% |
| R&D Expenses | $36.00M$37.00M | −2.7% |
| SG&A Expenses | $897.00M$823.00M | +9.0% |
| Operating Income | $2.37B$2.09B | +13.5% |
| Net Income | $1.93B$1.55B | +24.5% |
| EPS (Basic) | $4.11$3.24 | +26.9% |
| EPS (Diluted) | $4.09$3.22 | +27.0% |
| Shares Outstanding (Basic) | 468.80M477.66M | −1.9% |
| Shares Outstanding (Diluted) | 471.51M480.90M | −2.0% |
05—Questions
Frequently Asked Questions
Why did reported EPS rise much faster than adjusted EPS in Q3 2025?
Reported diluted EPS rose 27% to $4.09, while adjusted EPS rose 7% to $4.21. The gap reflects lower charges in the period: Q3 2025 had a net $11 million cost reduction benefit versus a $145 million charge in Q3 2024, and purchase accounting amortization from the Linde AG merger fell to $202 million from $246 million. The reported effective tax rate also dropped to 18.0% from 24.1%, largely because of a tax rate decrease in EMEA worth $156 million. Investors should weigh adjusted results more closely as the underlying measure of operating performance.
How strong is Linde's cash generation relative to its investment and shareholder return commitments?
For the nine months, operating cash flow was $7.3B, up 11%. Capex of $3.8B and acquisitions of $0.4B left roughly $3.1B before financing. Those funds, together with net new debt of about $1.9B, covered $3.2B in buybacks and $2.1B in dividends, with cash declining slightly to $4.5B. Debt growth outpacing cash flow is a point to monitor, since the company is funding part of its shareholder returns and capex with borrowing.
What is the scale of the Russia-related litigation risk?
Linde carries about $1.9B of liabilities recorded for Russia matters, has a further $1.2B contingent liability tied to terminated RusChemAlliance engineering projects where advance payments were previously booked as contract liabilities, and has a $0.7B contingency for Amur GPP matters. Management says it does not expect a material adverse impact on earnings and that its remaining Russian subsidiaries have immaterial investment value. Litigation is ongoing in St. Petersburg, Hong Kong arbitration and the Stockholm SCC, and the timing of resolution is hard to predict.
What drove the growth in sales and operating profit?
Sales growth of 3% in the quarter came mainly from pricing (+2%) and acquisitions (+1%), with currency adding 1% and volumes flat. Cost pass-through was flat. Operating profit growth came from higher pricing and productivity initiatives, which more than offset cost inflation. Engineering was a drag on sales, down 15% due to project timing, while Americas and EMEA were the main contributors, with Americas operating profit up 4% and EMEA up 11%.
Are there signs of balance sheet or leverage pressure?
Total debt increased to $25.9B from $21.6B, and short-term debt rose to $5.0B. Long-term debt of $18.6B is partly funded by new euro and Swiss franc issues. The company reports $5.0B and $1.5B revolving credit facilities with no financial maintenance covenants, with the $1.5B facility expiring December 3, 2025, and no borrowings outstanding. Management states it has sufficient liquidity and continues to hold strong ratings from Moody's and S&P. Equity rose modestly to $40.1B, so leverage has risen, though the company's liquidity position remains solid.
06—Continue